Protara Therapeutics Inc
NASDAQ:TARA

Watchlist Manager
Protara Therapeutics Inc Logo
Protara Therapeutics Inc
NASDAQ:TARA
Watchlist
Price: 5.75 USD 2.5% Market Closed
Market Cap: 221.9m USD

Net Margin
Protara Therapeutics Inc

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-52.9m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Protara Therapeutics Inc
Glance View

Market Cap
221.9m USD
Industry
Biotechnology

Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. The company is headquartered in New York City, New York and currently employs 31 full-time employees. The company went IPO on 2014-10-22. The firm is focused on identifying therapies for the treatment of cancer and rare diseases. The firm's pipeline includes TARA-002 and IV Choline Chloride. The firm's lead product pipeline is TARA 002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. IV choline chloride is an investigational, intravenous (IV) phospholipid substrate replacement therapy, which is in development for patients receiving parenteral nutrition (PN) who have intestinal failure-associated liver disease (IFALD).

TARA Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-52.9m
/
Revenue
0
What is the Net Margin of Protara Therapeutics Inc?

Based on Protara Therapeutics Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top